152 related articles for article (PubMed ID: 21434953)
1. Addition of prokinetic therapy to a PPI in reflux diseases.
Hsu YC; Lin HJ
Aliment Pharmacol Ther; 2011 Apr; 33(8):983-4; author reply 984-5. PubMed ID: 21434953
[No Abstract] [Full Text] [Related]
2. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
Nandurkar S
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
[No Abstract] [Full Text] [Related]
3. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
4. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.
Futagami S; Iwakiri K; Shindo T; Kawagoe T; Horie A; Shimpuku M; Tanaka Y; Kawami N; Gudis K; Sakamoto C
J Gastroenterol; 2010 Apr; 45(4):413-21. PubMed ID: 19997942
[TBL] [Abstract][Full Text] [Related]
5. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
Miwa H; Inoue K; Ashida K; Kogawa T; Nagahara A; Yoshida S; Tano N; Yamazaki Y; Wada T; Asaoka D; Fujita T; Tanaka J; Shimatani T; Manabe N; Oshima T; Haruma K; Azuma T; Yokoyama T;
Aliment Pharmacol Ther; 2011 Feb; 33(3):323-32. PubMed ID: 21118395
[TBL] [Abstract][Full Text] [Related]
6. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
7. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
[TBL] [Abstract][Full Text] [Related]
8. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
Juul-Hansen P; Rydning A
Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review.
Liu Q; Feng CC; Wang EM; Yan XJ; Chen SL
World J Gastroenterol; 2013 Dec; 19(47):9111-8. PubMed ID: 24379638
[TBL] [Abstract][Full Text] [Related]
10. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of therapy effects between esomeprazole plus mosapride citrate and botulinum toxin injection on vocal process granuloma].
Lei L; Yang H; Zhao Y; Zhang XS; Zou J; Ren J; Zheng YT; Ren JJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(13):1006-1009. PubMed ID: 29798164
[No Abstract] [Full Text] [Related]
12. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
Gallusi G; Pontone S
Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
[TBL] [Abstract][Full Text] [Related]
13. Which PPI?
Med Lett Drugs Ther; 2015 Jun; 57(1471):91. PubMed ID: 26079763
[No Abstract] [Full Text] [Related]
14. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
15. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
16. Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: prospective study.
Ezzat WF; Fawaz SA; Fathey H; El Demerdash A
J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):350-6. PubMed ID: 21777555
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of GORD. Emerging therapeutic targets and concepts.
Zerbib F
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor failure--what are the therapeutic options?
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
[TBL] [Abstract][Full Text] [Related]
20. New pharmacologic approaches in gastroesophageal reflux disease.
Armstrong D; Sifrim D
Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
